跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG - HSA Drug Approval Details
Approvals
/
HSA
/
ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG
Approved
THERAPEUTIC
ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG
SUN PHARMACEUTICAL INDUSTRIES LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Apr 24, 2020
Approval ID
831f6a66c5f65276
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
831f6a66c5f65276
Drug Name
ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG
Product Name
ONCOPROS - ABIRATERONE ACETATE TABLETS USP 250MG
Approval Number
SIN15933P
Approval Date
2020-04-24
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
L02BX03
Atc Item Name
abiraterone
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Active Ingredients
Abiraterone Acetate
250.00mg
ABIRATERONE ACETATE
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 24, 2020
Approval ID
831f6a66c5f65276
Type
Therapeutic
Back to HSA Approvals
